17-May-2024
No headlines found.
Globe Newswire (Wed, 15-May 7:00 AM ET)
Cibus to Participate in the BMO Global Farm to Market Conference
Globe Newswire (Mon, 13-May 7:00 AM ET)
Cibus Reports First Quarter Financial Results and Provides Business Update
Globe Newswire (Thu, 9-May 4:05 PM ET)
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
Globe Newswire (Thu, 25-Apr 7:00 AM ET)
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
Globe Newswire (Thu, 21-Mar 4:05 PM ET)
Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Globe Newswire (Tue, 19-Mar 8:30 AM ET)
Cibus to Participate in the 36th Annual Roth Conference
Globe Newswire (Wed, 13-Mar 7:35 AM ET)
Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call
Globe Newswire (Thu, 7-Mar 7:00 AM ET)
Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US
Globe Newswire (Mon, 26-Feb 7:00 AM ET)
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Cibus - Class A trades on the NASDAQ stock market under the symbol CBUS.
As of May 17, 2024, CBUS stock price climbed to $18.50 with 25,551 million shares trading.
CBUS has a beta of 1.61, meaning it tends to be more sensitive to market movements. CBUS has a correlation of 0.03 to the broad based SPY ETF.
CBUS has a market cap of $456.72 million. This is considered a Small Cap stock.
Last quarter Cibus - Class A reported $545,000 in Revenue and -$1.12 earnings per share. This beat revenue expectation by $155,000 and missed earnings estimates by -$.11.
The top ETF exchange traded funds that CBUS belongs to (by Net Assets): VTI, VXF.
CBUS support price is $17.60 and resistance is $19.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBUS stock will trade within this expected range on the day.